Biologic medications have transformed rheumatoid arthritis treatment, but what impact do they have on preventing joint surgeries? CAPA members Linda Wilhelm and Laurie Proulx worked with researchers to explore this question through a systematic review and multi-interest holder dialogue called DMARD Dialogues.

Read the report to learn about the evidence, key discussion themes, and what’s next for this important work. Visit our Advocacy & Policy page.